Loading...
Loading...
AMRS| Name | Value |
|---|---|
| Revenues | 71.1M |
| Cost of Revenue | 65.8M |
| Gross Profit | 5.3M |
| Operating Expense | 153.5M |
| Operating I/L | -148.2M |
| Other Income/Expense | -18.9M |
| Interest Income | 0.0M |
| Pretax | -167.1M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -167.3M |
Amyris, Inc. is a synthetic biotechnology company that operates in the clean health and beauty, and flavors and fragrance markets globally. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under various brand names such as Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN. Amyris also has a collaboration agreement for the development of a COVID-19 vaccine.
